LifeVantage Corporation (LFVN) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
LFVN Revenue Growth
Revenue Breakdown (FY 2025)
LFVN's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
LFVN Revenue Analysis (2014–2025)
As of May 8, 2026, LifeVantage Corporation (LFVN) generated trailing twelve-month (TTM) revenue of $195.3 million, reflecting significant decline in growth of -25.2% year-over-year. The most recent quarter (Q3 2026) recorded $43.7 million in revenue, down 10.7% sequentially.
Looking at the longer-term picture, LFVN's 5-year compound annual growth rate (CAGR) stands at -0.4%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $232.9 million in 2020.
Revenue diversification analysis shows LFVN's business is primarily driven by Protandim (61%), LifeVantage TrueScience Skin Care Regimen (36%), and Product and Service, Other (4%). With over half of revenue concentrated in Protandim, the company maintains significant focus in this area while developing other growth vectors.
When compared to Consumer Defensive sector peers including NATR (+7.3% YoY), NHTC (-10.5% YoY), and QNST (+14.7% YoY), LFVN has underperformed the peer group in terms of revenue growth. Compare LFVN vs NATR →
LFVN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| $195M | -25.2% | -0.4% | 5.3% | ||
| $480M | +7.3% | +4.5% | 5.2% | ||
| $40M | -10.5% | -8.5% | -4.5% | ||
| $1.1B | +14.7% | +17.4% | 0.6% | ||
| $5.0B | +3.7% | -1.9% | 8.8% | ||
| $925M | +8.3% | -4.0% | 5.5% |
LFVN Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $228.5M | +14.2% | $183.7M | 80.4% | $12.2M | 5.3% |
| 2024 | $200.2M | -6.2% | $158.7M | 79.3% | $4.3M | 2.2% |
| 2023 | $213.4M | +3.4% | $170.0M | 79.7% | $4.3M | 2.0% |
| 2022 | $206.4M | -6.3% | $168.3M | 81.5% | $7.6M | 3.7% |
| 2021 | $220.2M | -5.5% | $182.0M | 82.7% | $17.6M | 8.0% |
| 2020 | $232.9M | +3.1% | $195.0M | 83.7% | $15.5M | 6.6% |
| 2019 | $226.0M | +11.2% | $188.0M | 83.2% | $9.5M | 4.2% |
| 2018 | $203.2M | +1.9% | $168.4M | 82.9% | $10.3M | 5.1% |
| 2017 | $199.5M | -3.4% | $166.0M | 83.2% | $4.4M | 2.2% |
| 2016 | $206.5M | +8.5% | $172.6M | 83.6% | $13.4M | 6.5% |
See LFVN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LFVN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LFVN vs WMT
Side-by-side business, growth, and profitability comparison vs Walmart Inc..
Start ComparisonLFVN — Frequently Asked Questions
Quick answers to the most common questions about buying LFVN stock.
Is LFVN's revenue growth accelerating or slowing?
LFVN revenue declined -25.2% year-over-year, contrasting with the 5-year CAGR of -0.4%. TTM revenue fell to $195M. This reverses the prior growth trend.
What is LFVN's long-term revenue growth rate?
LifeVantage Corporation's 5-year revenue CAGR of -0.4% reflects the variable expansion pattern. Current YoY growth of -25.2% is below this long-term average.
How is LFVN's revenue distributed by segment?
LFVN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.